Breaking News, Collaborations & Alliances

SEQSTER, Praxis Extend Partnership

Aim to accelerate clinical trials, data collection, and real-world evidence generation across Praxis' clinical development programs.

Author Image

By: Charlie Sternberg

Associate Editor

SEQSTER, a healthcare technology company, and Praxis Precision Medicines Inc. have expanded their partnership to accelerate clinical trials, data collection, and real-world evidence (RWE) generation across Praxis’ clinical development programs. Building on early success in Praxis’ innovative Essential3 Program for Essential Tremor, SEQSTER’s platform continues to support the broader ENERGY program, Praxis’ comprehensive program advancing vormatrigine for the treatment of epi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters